Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Psychiatry Physician in La Jolla, CA
NPI: 1053467738Primary Employer
Kadima Neuropsychiatry Institute, Medical Corp
kadimanp.com
HQ Phone
Get M.D. David's Phone Numberphone_androidMobile
Get M.D. David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1992 - 2026
American Board of Psychiatry and Neurology
Psychiatry
University of California (San Diego) Medical Center
Residency • Psychiatry
1992 - 1995
University of Toronto Faculty of Medicine
Medical School
Until 1991
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 96130Evaluation of psychological test, first hour | 62 | 141 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 54 | 54 |
| 3 | 90867Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression) | 15 | 16 |
| 4 | 90868Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | 15 | 448 |
| 5 | G2083Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, | 14 | 72 |
Time to feel good: the therapeutic time course of antidepressants.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Psychiatry (Edgmont)
Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia.
A comparison of the safety of olanzapine and haloperidol in combination with benzodiazepines in emergency department patients with acute agitation.
Authors: Kaimana Macdonald, Gary Vilke
Publication Date: 2012-11
Lead Sponsor: COMPASS Pathways
Intervention / Treatment: DRUG: Psilocybin
Lead Sponsor: Brainsway
Intervention / Treatment: BEHAVIORAL: CBT-based, mobile-delivered, intervention platform
Lead Sponsor: COMPASS Pathways
Intervention / Treatment: DRUG: Psilocybin